Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Olam Coffee leverages key consumer trends with new upcycled ‘superfruit’ cáscara

Olam Coffee’s recent development of new ‘superfruit’ cáscara is a promising discovery as its cross-industry application will help realize the potential of upcycling on a mass scale, according to GlobalData, a leading data and analytics company. Carmen Bryan, Consumer Analyst at GlobalData, comments: “The global hot coffee market is valued at $108.4bn in 2020, offering a robust introductory market for the new superfruit. However, what really sells […]
Read more

Remote patient monitoring market set to surpass $645m by 2025 as COVID-19 pandemic drives growth

Remote patient monitoring (RPM) is set to benefit from the COVID-19 pandemic and the growing aging population around the world. The global market value for RPM is projected to grow by 18% in the next five years to surpass $645m by 2025, according to GlobalData, a leading data and analytics company. Kevin Dang, Medical Devices Analyst at GlobalData, comments: “With the global pandemic forcing many to remain at home, there is now an emphasis on patient-centered care that is becoming more dependent […]
Read more
,

Adidas’ filing documents reveal declining coverage of Reebok as it considers brand’s sale

Mentions of Reebok in Adidas’ 2020* filings have substantially reduced compared to previous years, with GlobalData’s Filing Analytics platform identifying steep declines in discussions around the Reebok brand, which could indicate that the company is likely considering a sale of the brand. Rinaldo Pereira, Senior Business Fundamentals Analyst at GlobalData, says: “Adidas’ acquisition of Reebok more than a decade ago aimed to place the company on a better footing against competitors such as Nike. However, the […]
Read more

DFS prospers as consumers seek home upgrades

Following today’s release of DFS figures for the 24 weeks ending 13 December; Amy Higginbotham, Retail Analyst at GlobalData, a leading data and analytics company, comments: “DFS reported a strong start to FY2020/21 as consumers continue to shift spend from holidays and leisure to the home. The furniture specialist performed particularly well in its Q1 […]
Read more

Inertial and global satellite navigation devices market set to reach $1.9bn by 2030, driven by network-centric warfare capability modernization initiatives

In the rapidly evolving network-centric battlefield, militaries across the globe are extensively using inertial navigation systems (INS) and global navigation satellite system (GNSS) devices for navigation, positioning, tracking and targeting applications. In fact, the global military INS & GNSS devices market is anticipated to reach $1.9bn by 2030, which is approximately 30% higher compared to […]
Read more

KBP Biosciences’ KBP-5074 has potential to become viable competitor to MRAs for CKD

KBP Biosciences recently shared results for its BLOCK-CKD Phase IIb study and the positive trial results suggest KBP-5074 may become a viable competitor to the already established non-steroidal mineralocorticoid receptor antagonists (MRAs) for chronic kidney disease (CKD), according to GlobalData, a leading data and analytics company. According to GlobalData’s Pharma Intelligence Center (PIC) drug database, KBP Biosciences has two leading products in development: KBP-5074 for uncontrolled hypertension in advanced CKD and KBP-7072 for infectious disease. Kajal Jaddoo, Associate Pharma Analyst at GlobalData, comments: “A benefit of KBP-5074 over other […]
Read more

SSA construction sector will fall into deep recession in 2020 with 2021 rebound output level far less than 2019

Construction output growth forecast for Sub-Saharan Africa (SSA) in 2020 has been adjusted further to -5.2% from the previous forecast of -4.9%, according to GlobalData, a leading data and analytics company. The current revision reflects the deep impact on the region’s economic activity and investment growth stemming from the wider global slowdown, the outbreak of COVID-19 in the region and possibly a lack of available external […]
Read more

Entresto’s potential first-mover advantage in largely untapped HFpEF market could be extremely lucrative for Novartis

A positive recommendation from an FDA Advisory Committee has set Novartis’ Entresto (sacubitril/valsartan) on track to become the first drug to be approved for the treatment of heart failure with preserved ejection fraction (HFpEF). The potential label expansion could prove to be extremely lucrative for Novartis, providing the company with a first-mover advantage in this […]
Read more

COVID-19 has left a third of areas in America with limited ICU capacity

The growing rate of new COVID-19 cases indicates the US is facing a major crisis of hospital shortages not yet seen in this pandemic, and there is an expected near-doubling of hospitalizations and intensive care unit (ICU) admissions before year’s end, says GlobalData, a leading data and analytics company. Topias Lemetyinen, Pharma Analyst at GlobalData, […]
Read more

JDRF’s T1Detect population screening could revolutionize type 1 diabetes awareness and management

Juvenile Diabetes Research Foundation (JDRF) recently announced the launch of its ground-breaking screening initiative for type 1 diabetes (T1D), T1Detect, which aims to make early detection of T1D easier and more accessible to the broader population. This initiative will revolutionize awareness and management of the disease going forward as it will open up the market for preventative therapeutics and other disease-modifying therapies, says GlobalData, a leading data and analytics company. Samisha Khangaonkar, Pharma Analyst at GlobalData, comments: “Approximately 85% […]
Read more

Roche’s Ocrevus set to top $7.6bn in sales by 2028, backed by new dosing approval in the MS market

Following the news that the US Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for Roche’s Ocrevus (ocrelizumab) in patients with relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS); Sarah Elsayed, MBA, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “Ocrevus boasts a superior pharmacological profile in the MS market due to its high efficacy, good tolerability and convenient six-month dosing regimen via intravenous infusion (IV). The new FDA approval will further improve […]
Read more

Dixons Carphone mitigates decline in store sales with online innovation

Following today’s release of Dixons Carphone figures for H1 FY2020/21, Zoe Mills, Senior Retail Analyst at GlobalData, a leading data and analytics company, comments: “Dixons Carphone has prospered despite the pandemic appealing to consumers looking to make the time spent at home more enjoyable, with investment in TVs, fitness trackers and computing seeing the strongest performance throughout H1 2020/21. […]
Read more

Demand for DIY continues to bolster Travis Perkins

Following today’s release of Travis Perkins figures for October and November 2020, Georgina Sreeves, Retail Analyst at GlobalData, a leading data and analytics company, comments: “Wickes and Toolstation remain Travis Perkins’ saving grace amid the pandemic; the businesses grew 13.7% and 41.0% respectively during October and November due to ongoing high demand for DIY. “Given its strong performance, Travis Perkins is following many other essential retailers by returning the business-rates relief […]
Read more

H&M has paid the price for being a digital laggard

Following today’s release of H&M figures for Q4 and FY2019/20, Emily Salter, Retail Analyst at GlobalData, a leading data and analytics company, comments: “The improvement in H&M’s global sales performance in Q3 (-18.7%) continued into Q4, with sales from 1 September to 21 October only falling 3% in local currencies. However, the second wave of COVID-19 in […]
Read more
1 … 46 47 48 49 50 … 93